SUMMARY Treatment with plasma exchange, steroids, immunosuppressant drugs and cytotoxic chemotherapy was effective in two cases of cancer-associated Eaton-Lambert myasthenic syndrome. The clinical improvement noted during treatment was accompanied by improvement in the electrophysiological abnormality; this was much more marked in abductor digiti minimi and trapezius than in extensor digitorum brevis.
The myasthenic syndrome is a disorder of neuromuscular transmission characterised by weakness and muscular atrophy.' 2 Weakness is most marked in the proximal muscles of the legs, and it is generally worse at rest, improving with exercise. Ocular muscles and eyelids are usually spared. Many patients complain of a dry mouth and other autonomic disturbances may occur. '-3 These features distinguish the disorder from myasthenia gravis. The diagnosis is confirmed by the characteristic electrophysiological findings. The compound muscle action potential evoked by a single nerve stimulation is of low amplitude, and a decremental response is observed during low-frequency repetitive nerve stimulation. However, stimulation at a faster rate elicits an incremental response, sometimes preceded by an initial decrement. ' 24-6 It has been shown that the myasthenic syndrome is a pre-synaptic disorder in which the number of quanta of acetylcholine released by each nerve impulse is reduced.4 This results from binding of an IgG autoantibody to nerve terminal determinants.7 The suggestion that the disease had an autoimmune basis' led to treatment with plasma exchange and immunosuppressive drugs.7- '0 In assessing the response to treatment, the distibution of weakness and the electrophysiological abnormality must be carefully considered. Improvement has been reported during treatment with guanidine,5 4-aminopyridine and related compounds" '3 and with steroid therapy, '4 '" plasma exchange7-' 6 and immunosuppressive drugs.8 9 6 7 This improvement has been correlated with an increase in the amplitude of the initial evoked compound muscle action potential.'0 '7 These studies7'-' '6 '7 have concerned patients with the myasthenic syndrome unrelated to carcinoma, apart from two cases of carcinoma-associated myasthenic syndrome,7 and one patient with multiple myeloma. '1 In this paper we describe the response to treament with plasma exchange and cytotoxic chemotherapy, and the distribution of the clinical and electrophysiological abnormality, in two patients with carcinoma-associated myasthenic syndrome. Initial compound muscle action potential amplitude On day 1, when the patient had not received steroids for 48 hours, the initial compound muscle action potential amplitudes were lowest in abductor digiti minimi (10% of normal), and extensor digitorum brevis (44% of normal), but less abnormal in trapezius (73% of normal). There was a slight increase in the initial compound muscle action potential amplitude in the noon and afternoon studies in the trapezius but little or no diurnal variation occurred in extensor digitorum brevis and abductor digiti minimi (fig 1) . On day 2, studies were carried out in the afternoon after an early morning dose of prednisolone; there was no change in the initial compound muscle action potential amplitude compared with the recordings of the previous day.
On day 45, 3 weeks after completion of a course of eight plasma exchanges, and after two cytotoxic treatments, the initial compound muscle action potential amplitudes were increased in two muscles. In the trapezius the amplitude was normal; in the abductor digiti minimi the amplitude was twice the pre-treatment value but there was no change in the extensor digitorum brevis. These changes in initial compound muscle action potential amplitude broadly correlated with the clinical observations of a greater increase in proximal than in distal muscles during the period of treatment. The slight relapse at day 150-160 was accompanied by a reduction in that treatment of myasthenic syndrome associated with carcinoma is worthwhile and effective, and that a similar protocol should be followed in the two groups. In our Case 1 cytotoxic chemotherapy seemed to induce a more complete and sustained remission. An earlier report25 also described improvement after successful treatment of the carcinoma but this has not been generally noted.28
The response to treatment in myasthenic syndrome can be monitored by electrophysiological tests, in particular by the size of the evoked compound muscle action potential, the effect of stimulation at rapid ratesS 29 and the effect of short periods of voluntary activity.' 24 The size of the initial response increases during treatment with guanidine,5 4 aminopyridine," 12 [3] [4] diaminopyridine (DAP),13 plasma exchange7-'°and steroid therapy. '4 '5 30 31 Other substances also have this effect, including calcium gluconate, edrophonium and decamethonium,5 caffeine32 and choline.28
In Case 1 the amplitude of the initial compound muscle action potential in trapezius was normal following treatment but there was less marked improvement in abductor digiti minimi and extensor digitorum brevis. Following voluntary activation, the amplitude of the initial compound muscle action potential in abductor digiti minimi was normal at this time (day 45), but in extensor digitorum brevis the response was still small (fig 1) . In both cases post-contraction facilitation of the compound muscle action potential was most marked in abductor digiti minimi, than in other muscles ( 
